May 13, 2021Blogs, News
My Brother Stanley Campbell and
May 13, 2021Blogs, News
My Brother Stanley Campbell and EagleForce were enlisted by Gen. Gustave F. Perna, chief operations officer for Operation Warp Speed, to create the USA Vaccine rollout program.
By Luther Campbell
I WROTE THIS ARTICLE FEBRUARY 14 IT WAS NEVER RELEASED
If Florida Gov. Ron DeSantis and Miami-Dade Mayor Daniela Levine Cava really wanted to find out which communities desperately need more Covid-19 vaccines, all they got to do is talk to my brother, Stanley Campbell.
Stanley is chief executive of EagleForce Health, a tech company that’s developed an application called myVax that allows healthcare providers and government health agencies to schedule appointments and track who has gotten their shots. In real time, the mayor and the governor would be able to see when and where a shot is being administered.
MyVax could be a game changer, but this type of technology would significantly expose the race disparities in the vaccine rollout. And our elected officials don’t want that to happen.
While I take pride in being a Hip-Hop icon who started the music industry’s first independent rap record label, Stanley has me beat. He’s a former Navy pilot and counterterrorism expert with a background in physics and mathematics who’s an icon in the world of big data management and predictive analytics.
Although Stanley historically worked primarily with the Department of Defense, the company in 2005 developed a computer database that helped the police department in Wichita, KS, narrow down the list of suspects and crack the case of the BTK killer. The database allowed detectives to zero in on Dennis Rader, who was convicted and is serving a life sentence for 10 murders committed in Wichita and nearby Park City between 1974 and 1991.
Stanley and EagleForce were enlisted by Gen. Gustave F. Perna, chief operations officer for Operation Warp Speed, to create the program. But the Trump administration subsequently decided not to use myVax as part of the vaccine rollout because it would have meant paying a black man billions of dollars for creating it. So Stanley has been going directly to healthcare providers, as well as local and state government officials. MyVax is currently being used in St. Louis and the entire state of Maryland. Miami Mayor Francis Suarez endorsed myVax in October of last year ahead of the vaccine rollout.
Yet, DeSantis and Levine Cava haven’t shown any interest. Maybe they are afraid myVax will confirm that they are mostly vaccinating well-to-do, white senior citizens. With the app, the mayor could, as an example, see how many people were vaccinated at different sites throughout Miami-Dade on a daily basis. For instance, if the site at Zoo Miami vaccinated 10,000 people, but the one at the Miami-Dade College North Campus vaccinated 5,000 people, the county would know where to route more doses.
It’s a system that makes the entire vaccination rollout transparent. And that’s not something DeSantis and Cava want
By LUTHER CAMPBELL
FOLLOW ME
IG @unclelukereal1
Twitter @unclelukereal1
Youtube UncleLukeTV
https://lukerecord.com/my-brother-stanley-cam...t-program/
TOODLES
3
1
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...
Continue Reading
A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...
Continue Reading
Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...
Continue Reading
First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...
Continue Reading
A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...
Continue Reading
A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...
Continue Reading
Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...
Continue Reading
Top 5 Most Recently Viewed Articles
Insights from APA Corporation's Q3 2024 Financial Update HOUSTON -- APA Corporation (Nasdaq: APA) has released key information regarding its third-quarter 2024 financial and operational results. This supplemental information serves as a guide for investors, analysts, and stakeholders to help them form their own estimates regarding the company's performance. Understanding...
Continue Reading
Insights on the US Coffee Market Growth The US coffee market is currently gearing up for an exciting decade ahead, with projections indicating it could reach USD 150.88 billion by 2034, growing at a compound annual growth rate (CAGR) of 5.8% from 2025. This surge is largely influenced by shifting consumer preferences towards premium and specialty coffee, along with an...
Continue Reading
Understanding the Upcoming Earnings Announcement Great Lakes Dredge & Dock (NASDAQ: GLDD) is gearing up for its quarterly earnings report, and investors are eager to glean insights from the announcement. The anticipation is palpable as analysts forecast an earnings per share (EPS) of $0.09, signalling potential growth for the company. Market Reactions and Guidance It's...
Continue Reading
Calmére Estate Winery Changes Hands in Major Sale Napa Valley has long been a beacon for wine enthusiasts and savvy investors alike. The recent transaction involving Calmére Estate Winery showcases the continued potential of this iconic region. The winery, known for its exquisite Chardonnay and Pinot Noir, has been a part of the Carneros American Viticultural Area (AVA)...
Continue Reading
Mr. Splash Car Wash Takes a Strategic Step Forward Mr. Splash Car Wash, a notable name in the express car wash industry, has recently entered into a strategic partnership with NBA stars Giannis and Thanasis Antetokounmpo, along with Michael Carter-Williams. This collaboration aims to elevate the brand's presence in the Midwest, showcasing Mr. Splash's commitment to...
Continue Reading